Parabilis Medicines, Inc.

PBLS

PBLSParabilis Medicines, Inc. US flag

NASDAQ

29.20

USD

-0.38

- -

95.63MMarket Cap

Income Statement (USD)

API ChatGPT

	2024 Y	2025 Y
As of date	12/31/2024	12/31/2025

Sales/Revenue/Turnover	- -	- -
+ Sales & Services Revenue	- -	- -
- Cost of Revenue	- -	- -
+ Cost of Goods & Services	- -	- -
Gross Profit	- -	- -
+ Other Operating Income	- -	- -
- Operating Expenses	126	152
+ Selling, General & Admin	25	26
+ Research & Development	101	126
+ Other Operating Expense	- -	- -
Operating Income (Loss)	-126	-152
- Non-Operating (Income) Loss	-8	-6
+ Interest Expense, Net	-5	-2
+ Interest Expense	1	2
- Interest Income	6	3
+ Other Non-Op (Income) Loss	-3	-4
Pretax Income	-118	-146
- Income Tax Expense (Benefit)	- -	- -
- (Income) Loss from Affiliates	- -	- -
Income (Loss) from Cont Ops	-118	-146
- Net Extraordinary Losses (Gains)	- -	- -
+ Discontinued Operations	- -	- -
+ Extraord. & Accounting Changes	- -	- -
Income (Loss) Incl. MI	-118	-146
- Minority Interest	- -	- -
Net Income, GAAP	-118	-146
- Preferred Dividends	44	41
- Other Adjustments	- -	- -
Net Income Avail to Common, GAAP	-161	-187
EBIT	-126	-152
EBITDA	-124	-150
EBITDA Margin (%)	- -	- -
EBITA	-126	-152
Gross Margin (%)	- -	- -
Operating Margin (%)	- -	- -
Profit Margin (%)	- -	- -
Sales per Employee	- -	- -
Dividend per Share	- -	- -
Depreciation Expense	2	2
Basic Weighted Avg Shares	80	80
Basic EPS, GAAP	-2.01	-2.33
Basic EPS from Cont Ops	-1.47	-1.82
Diluted Weighted Avg Shares	80	80
Diluted EPS, GAAP	-2.01	-2.33
Diluted EPS from Cont Ops	-1.47	-1.82

Balance Sheet (USD)

API ChatGPT

	2024 Y	2025 Y
As of date	12/31/2024	12/31/2025

Total Current Assets	92	29
+ Cash, Cash Equivalents & STI	88	28
+ Cash & Cash Equivalents	47	28
+ ST Investments	41	- -
+ Accounts & Notes Receiv	- -	- -
+ Accounts Receivable, Net	- -	- -
+ Notes Receivable, Net	- -	- -
+ Loans Receivable, Net	- -	- -
+ Other Receivable, Net	- -	- -
+ Inventories	- -	- -
+ Raw Materials	- -	- -
+ Work In Process	- -	- -
+ Finished Goods	- -	- -
+ Inventory Adjustments	- -	- -
+ Other Inventory	- -	- -
+ Other ST Assets	4	2
+ Misc ST Assets	- -	- -
+ Prepaid Expenses	- -	- -
+ ST Derivative & Hedging Assets	- -	- -
+ ST Assets Held-for-Sale	- -	- -
+ ST Deferred Tax Assets	- -	- -
Total Noncurrent Assets	57	51
+ Property, Plant & Equip, Net	53	46
+ Property, Plant & Equip	63	59
- Accumulated Depreciation	10	13
+ LT Investments & Receivables	- -	- -
+ LT Investments	- -	- -
+ LT Receivables	- -	- -
+ Other LT Assets	4	5
+ Total Intangible Assets	- -	- -
+ Goodwill	- -	- -
+ Other Intangible Assets	- -	- -
+ LT Deferred Tax Assets	- -	- -
+ LT Derivative & Hedging Assets	- -	- -
+ Misc LT Assets	4	5
Total Assets	149	81
+ Payables & Accruals	16	26
+ Accounts Payable	10	17
+ Accrued Taxes	- -	- -
+ Interest & Dividends Payable	- -	- -
+ Other Payables & Accruals	7	8
+ ST Debt	9	21
+ ST Borrowings	2	13
+ ST Finance Leases	7	8
+ Other ST Liabilities	7	10
+ Deferred Revenue	- -	- -
+ Derivatives & Hedging	- -	- -
+ Deferred Tax Liabilities	- -	- -
+ Misc ST Liabilities	7	10
Total Current Liabilities	32	57
+ LT Debt	57	38
+ LT Borrowings	13	- -
+ LT Finance Leases	44	38
+ Other LT Liabilities	4	3
+ Accrued Liabilities	- -	- -
+ Pension Liabilities	- -	- -
+ Deferred Revenue	- -	- -
+ Deferred Tax Liabilities	- -	- -
+ Derivatives & Hedging	- -	- -
+ Misc LT Liabilities	4	3
Total Noncurrent Liabilities	60	41
Total Liabilities	93	97
+ Preferred Equity and Hybrid Capital	440	510
+ Share Capital & APIC	12	15
+ Common Stock	- -	- -
+ Additional Paid in Capital	12	15
- Treasury Stock	- -	- -
+ Retained Earnings	-396	-542
+ Other Equity	- -	- -
Equity Before Minority Interest	56	-17
+ Minority/Non Controlling Interest	- -	- -
Total Equity	56	-17
Total Liabilities & Equity	149	81
Shares Outstanding	118	118
Number of Employees	- -	- -
Capital Leases - Total	51	46
Net Debt	-32	-15
Net Debt to Equity	-56.69	88.56
Tangible Common Equity Ratio	-257.24	-651.44
Current Ratio	2.84	0.52
Cash Conversion Cycle	- -	- -

Cash Flow Statement (USD)

API ChatGPT

	2024 Y	2025 Y
As of date	12/31/2024	12/31/2025

+ Net Income	-118	-146
+ Depreciation & Amortization	2	2
+ Non-Cash Items	11	11
+ Stock-Based Compensation	4	3
+ Deferred Income Taxes	- -	- -
+ Asset Impairment Charge	- -	- -
+ Other Non-Cash Adj	7	7
+ Chg in Non-Cash Work Cap	1	9
+ (Inc) Dec in Accts Receiv	- -	- -
+ (Inc) Dec in Inventories	- -	- -
+ (Inc) Dec in Prepaid Assets	-2	2
+ Inc (Dec) in Accts Payable	9	14
+ Inc (Dec) in Other	-6	-6
+ Net Cash From Disc Ops	- -	- -
Cash from Operating Activities	-104	-124
+ Change in Fixed & Intang	- -	- -
+ Disp in Fixed & Intang	- -	- -
+ Disp of Fixed Prod Assets	- -	- -
+ Disp of Intangible Assets	- -	- -
+ Acq of Fixed & Intang	-1	- -
+ Acq of Fixed Prod Assets	-1	- -
+ Acq of Intangible Assets	- -	- -
+ Cash (Repurchase) of Equity	- -	- -
+ Increase in Capital Stock	- -	- -
+ Decrease in Capital Stock	- -	- -
+ Net Change in LT Investment	31	40
+ Dec in LT Investment	122	57
+ Inc in LT Investment	-91	-17
+ Net Cash From Acq & Div	- -	- -
+ Cash from Divestitures	- -	- -
+ Cash for Acq of Subs	- -	- -
+ Cash for JVs	- -	- -
+ Other Investing Activities	- -	- -
+ Net Cash From Disc Ops	- -	- -
Cash from Investing Activities	30	40
+ Dividends Paid	- -	- -
+ Net Cash From Debt	- -	-3
+ Cash From Debt	- -	- -
+ Repayments of Debt	- -	-3
+ Other Financing Activities	78	67
+ Net Cash From Disc Ops	- -	- -
Cash from Financing Activities	78	64
Effect of Foreign Exchange Rates	- -	- -
Net Changes in Cash	5	-20
EBITDA	-124	-150
EBITDA Margin (%)	- -	- -
Free Cash Flow	-104	-124
Net Cash Paid for Acquisitions	- -	- -
Free Cash Flow to Firm	- -	- -
Free Cash Flow to Equity	- -	-99
Free Cash Flow per Basic Share	-1.3	-1.54
Price/Free Cash Flow	- -	- -
Cash Flow to Net Income	0.88	0.85
Capital Expenditures	-1	- -